Login / Signup

Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study.

Kei MoriyaKiyoshi AsadaShota SuzukiMasahide EnomotoYukihisa FujinagaYuki TsujiTadashi NamisakiHitoshi Yoshiji
Published in: Medicine (2022)
The prospective clinical interventional study was designed to assess the supportive effect of glucosyl hesperidin on hepatic function in patients with PBC receiving basic ursodeoxycholic acid treatment.
Keyphrases
  • open label
  • double blind
  • clinical trial
  • squamous cell carcinoma
  • phase iii
  • randomized controlled trial
  • radiation therapy
  • placebo controlled
  • phase ii study
  • replacement therapy
  • rectal cancer
  • locally advanced